• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of Hepatocellular Cancer in the time of SARS-CoV-2.

作者信息

Sharma Rohini, Pinato David J

机构信息

Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK.

出版信息

Liver Int. 2020 Aug;40(8):1823-1825. doi: 10.1111/liv.14517.

DOI:10.1111/liv.14517
PMID:32416633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7276833/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66a6/7576890/76e56727cc5e/LIV-40-1823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66a6/7576890/76e56727cc5e/LIV-40-1823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66a6/7576890/76e56727cc5e/LIV-40-1823-g001.jpg

相似文献

1
Management of Hepatocellular Cancer in the time of SARS-CoV-2.2019冠状病毒病时期肝细胞癌的管理
Liver Int. 2020 Aug;40(8):1823-1825. doi: 10.1111/liv.14517.
2
Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor.新型冠状病毒肺炎对慢性肝病和肝肿瘤患者的临床影响
Updates Surg. 2020 Jun;72(2):237-239. doi: 10.1007/s13304-020-00804-8.
3
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective.COVID-19 大流行期间原发性肝脏恶性肿瘤的管理：多学科角度的风险缓解建议。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):765-775. doi: 10.1016/S2468-1253(20)30182-5. Epub 2020 Jun 6.
4
Management of liver diseases during the pandemic of coronavirus disease-19.2019冠状病毒病大流行期间的肝病管理
Clin Mol Hepatol. 2020 Jul;26(3):243-250. doi: 10.3350/cmh.2020.0111. Epub 2020 Jun 23.
5
Management of hepatocellular carcinoma in the time of COVID-19.2019冠状病毒病时期肝细胞癌的管理
Ann Oncol. 2020 Aug;31(8):1084-1085. doi: 10.1016/j.annonc.2020.04.007. Epub 2020 Apr 21.
6
Multidetector computed tomography chest findings of coronavirus disease 2019 pneumonia in patient with hepatocellular carcinoma.肝细胞癌患者新型冠状病毒肺炎的胸部多排螺旋计算机断层扫描表现
Eur J Gastroenterol Hepatol. 2020 Sep;32(9):1265-1266. doi: 10.1097/MEG.0000000000001823.
7
Five recommendations for loco-regional treatments of hepatocellular carcinoma during the COVID-19 pandemic.COVID-19大流行期间肝细胞癌局部区域治疗的五项建议。
Dig Liver Dis. 2020 Sep;52(9):950-952. doi: 10.1016/j.dld.2020.05.035. Epub 2020 Jun 16.
8
Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver.评估 COVID-19 对肝病患者管理的影响：意大利肝病研究协会的全国性调查。
Dig Liver Dis. 2020 Sep;52(9):937-941. doi: 10.1016/j.dld.2020.07.008. Epub 2020 Jul 10.
9
Temperature-dependent surface stability of SARS-CoV-2.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的温度依赖性表面稳定性
J Infect. 2020 Sep;81(3):452-482. doi: 10.1016/j.jinf.2020.05.074. Epub 2020 Jun 3.
10
COVID-19.新型冠状病毒肺炎
J Med Ultrason (2001). 2020 Apr;47(2):339. doi: 10.1007/s10396-020-01014-w.

引用本文的文献

1
Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study.新型冠状病毒肺炎对肝细胞癌1年生存结局的影响：一项多中心队列研究
Cancers (Basel). 2023 Jun 27;15(13):3378. doi: 10.3390/cancers15133378.
2
Molecular mechanisms implicated in SARS-CoV-2 liver tropism.与 SARS-CoV-2 肝脏嗜性相关的分子机制。
World J Gastroenterol. 2022 Dec 28;28(48):6875-6887. doi: 10.3748/wjg.v28.i48.6875.
3
Screening, Surveillance, and Management of Hepatocellular Carcinoma During the COVID-19 Pandemic: a Narrative Review.

本文引用的文献

1
COVID-19: The European institute of oncology as a "hub" centre for breast cancer surgery during the pandemic in Milan (Lombardy region, northern Italy) - A screenshot of the first month.新冠疫情期间米兰（意大利北部伦巴第大区）的欧洲肿瘤研究所作为乳腺癌手术“枢纽”中心——首月截屏
Eur J Surg Oncol. 2020 Jun;46(6):1180-1181. doi: 10.1016/j.ejso.2020.04.026. Epub 2020 Apr 24.
2
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.《COVID-19 大流行期间肝病学和肝移植提供者的临床最佳实践建议：AASLD 专家小组共识声明》。
Hepatology. 2020 Jul;72(1):287-304. doi: 10.1002/hep.31281.
3
在 COVID-19 大流行期间肝细胞癌的筛查、监测和管理：叙述性综述。
J Gastrointest Cancer. 2023 Jun;54(2):408-419. doi: 10.1007/s12029-022-00830-2. Epub 2022 May 2.
4
Impact of COVID-19 Pandemic on Intervals and Outcomes of Repeated Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma.2019年冠状病毒病大流行对肝细胞癌患者重复经动脉化疗栓塞术的间隔时间和结局的影响
Front Oncol. 2021 May 6;11:602700. doi: 10.3389/fonc.2021.602700. eCollection 2021.
5
Economic Distress of Breast Cancer Patients Seeking Treatment at a Tertiary Cancer Center in Mumbai during COVID-19 Pandemic: A Cohort Study.《COVID-19 大流行期间，孟买一家癌症专科医院寻求治疗的乳腺癌患者的经济困境：一项队列研究》。
Asian Pac J Cancer Prev. 2021 Mar 1;22(3):793-800. doi: 10.31557/APJCP.2021.22.3.793.
6
WGO Guidance for the Care of Patients With COVID-19 and Liver Disease.世界胃肠病组织（WGO）关于 COVID-19 与肝病患者照护的指导意见。
J Clin Gastroenterol. 2021 Jan;55(1):1-11. doi: 10.1097/MCG.0000000000001459.
7
A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic.新型冠状病毒肺炎大流行期间癌症护理临床实践指南及治疗建议综述
Cancers (Basel). 2020 Aug 29;12(9):2452. doi: 10.3390/cancers12092452.
8
Can thrombotic events be a major concern in hepatocellular carcinoma patients under systemic treatment during SARS-Cov-2?在感染SARS-CoV-2期间接受全身治疗的肝细胞癌患者中，血栓形成事件会成为一个主要问题吗？
Liver Int. 2020 Dec;40(12):3140. doi: 10.1111/liv.14545. Epub 2020 May 30.
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.
2019冠状病毒病大流行期间肝病患者的护理：欧洲肝脏研究学会-欧洲临床微生物学与传染病学会立场文件
JHEP Rep. 2020 Jun;2(3):100113. doi: 10.1016/j.jhepr.2020.100113. Epub 2020 Apr 2.
4
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
5
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南：肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
6
Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study.索拉非尼治疗肝细胞癌的起始剂量：一项回顾性多机构研究
J Clin Oncol. 2017 Nov 1;35(31):3575-3581. doi: 10.1200/JCO.2017.73.8245. Epub 2017 Sep 5.
7
Review article: delivering precision oncology in intermediate-stage liver cancer.综述文章：在中晚期肝癌中实现精准肿瘤学。
Aliment Pharmacol Ther. 2017 Jun;45(12):1514-1523. doi: 10.1111/apt.14066. Epub 2017 Apr 25.